Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation

From: the New Englad Journal of Medicine

Many patients requiring pacemaker or implantable cardioverter–defibrillator (ICD) surgery are taking warfarin. For patients at high risk for thromboembolic events, guidelines recommend bridging therapy with heparin; however, case series suggest that it may be safe to perform surgery without interrupting warfarin treatment. There have been few results from clinical trials to support the safety and efficacy of this approach.

Complete study>>


< Back | Printer Friendly Page

In the News

06/25/2014

Western Maine Affiliate deploys AED

Oxford Federal Credit Union


06/14/2014

Senate Subcommittee Action on AED Program

Approval of more funds for rural AEDs

All News Stories »